The US Federal Trade Commission approved the purchase of the Irish pharmaceutical company Shire by Japanese Takeda Pharmaceutical, the largest pharmaceutical company in Asia, for 46 billion pounds sterling. The message of Takeda said that the deal would lead the Japanese company into the top 10 pharmaceutical companies in the world in terms of revenue. Takeda expects that the deal, which is the largest in the history of deals of the Japanese companies with the purchase of foreign assets, will be closed in the first half of 2019. The deal has yet to be agreed in a number of other countries, including the EU, Japan and China.
Gold prices move closer to $1,800 as COVID-19 cases surpasses 10 million worldwide29.06.2020
Japanese bank sees dim outlook for tourist hub Osaka24.06.2020
Spirit AeroSystems shares fall; the company holds discussions with Boeing02.06.2020
Russian oil and gas production cuts to 9.39 million bpd in May: Interfax